Diagnosis of Wilson's Disease: A Comprehensive Review

REFERENCES

• Wilson S AK. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain 1912; 34: 295–509
   Google Scholar
• Rumpel A. Uber das Wesen und die Bedeutung der Leberveranderungen und der pigmentierunen bie den damit verbunden Fallen von Pseudosclerose, zugleich ein Beitrag zur Lehre von der Pseudosclerose (Westphal-Strumpell). Dtsch Z Nervenheilk 1913; 49: 54–73
   Google Scholar
• Vogt A. Kupfer und silber aufgespeichert in Auge, Leber, Milz und Nieren als Symptom der Pseudosklerose. Klin Mbl Augenheilk 1929; 83: 417–419
   Google Scholar
• Haurowitz F. Ubereine anamoliedes kupferstoffwechsels. Hoppe-Seyler Z. Physiol Chemie 1930; 190: 72–74
   Google Scholar
• Glazebrook A J. Wilson's disease. Edin Med J 1945; 52: 83–87
   Google Scholar
• Gerlach W, Rohrschneider W. Besteht das Pigment des Kayser-Fleischerchen Hornhautringes aus Silber?. Klin Wschr 1934; 13: 48–49
   Google Scholar
• Policard A, Bonner P, Bonamour G. Etude histospectrographique de l'anneasu corneen de Kayser-Fleischer. C R Soc Biol (Paris) 1936; 122: 1120–1122
   Google Scholar
• Kayser B. Ueber einen Fall von angeborener grunlicher Verfarbung der Cornea. Klin Mbl Augenheilk 1902; 40: 22–25
   Google Scholar
• Scheinberg I H, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration. Science 1952; 116: 484–485
   PubMed Web of Science ®Google Scholar
• Walshe J M. History of Wilson's disease: 1912 to 2000. Mov Disord 2006; 21: 142–147
   Google Scholar
• Scheinberg I, Sternlieb I. Wilson's Disease. Major Probl Intern Med 1984; 23: 1–24
   Google Scholar
• Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990; 12: 1234–1239
   PubMed Web of Science ®Google Scholar
• Bachmann H, Lossner J, Gruss B, Ruchholtz U. The epidemiology of Wilson's disease in the German Democratic Republic and current problems from the viewpoint of population genetics. Psychiatr Neurol Med Psychol (Leipz) 1979; 31: 393–400
   Google Scholar
• Saito T. An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health 1981; 35: 274–280
   PubMed Web of Science ®Google Scholar
• Endo F, Taketa K, Nakamura K, Awata H, Tanoue A, Eda Y, Matsuda I. Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease. J Inherit Metab Dis 1994; 17: 616–620
   Google Scholar
• Ohura T, Abukawa D, Shiraishi H, Yamaguchi A, Arashima S, Hiyamuta S, Tada K, Iinuma K. Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics. J Inherit Metab Dis 1999; 22: 74–80
   Google Scholar
• Yamaguchi Y, Aoki T, Arashima S, Ooura T, Takada G, Kitagawa T, Shigematsu Y, Shimada M, Kobayashi M, Itou M, Endo F. Mass screening for Wilson's disease: results and recommendations. Pediatr Int 1999; 41: 405–408
   Google Scholar
• Olivarez L, Caggana M, Pass K A, Ferguson P, Brewer G J. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet 2001; 65: 459–463
   PubMed Web of Science ®Google Scholar
• Hahn S H, Lee S Y, Jang Y J, Kim S N, Shin H C, Park S Y, Han H S, Yu E S, Yoo H W, Lee J S, Chung C S, Lee S Y, Lee D H. Pilot study of mass screening for Wilson's disease in Korea. Mol Genet Metab 2002; 76: 133–136
   PubMed Web of Science ®Google Scholar
• Dedoussis G V, Genschel J, Sialvera T E, Bochow B, Manolaki N, Manios Y, Tsafantakis E, Schmidt H. Wilson disease: high prevalence in a mountainous area of Crete. Ann Hum Genet 2005; 69: 268–274
   PubMed Web of Science ®Google Scholar
• Kroll C A, Ferber M J, Dawson B D, Jacobson R M, Mensink K A, Lorey F, Sherwin J, Cunningham G, Rinaldo P, Matern D, Hahn S H. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Mol Genet Metab 2006; 89: 134–138
   PubMed Web of Science ®Google Scholar
• Garcia-Villarreal L, Daniels S, Shaw S H, Cotton D, Galvin M, Geskes J, Bauer P, Sierra-Hernandez A, Buckler A, Tugores A. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study. Hepatology 2000; 32: 1329–1336
   PubMed Web of Science ®Google Scholar
• Owada M, Suzuki K, Fukushi M, Yamauchi K, Kitagawa T. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin. J Pediatr 2002; 140: 614–616
   Google Scholar
• Loudianos G, Dessi V, Lovicu M, Angius A, Figus A, Lilliu F, De Virgiliis S, Nurchi A M, Deplano A, Moi P, Pirastu M, Cao A. Molecular characterization of Wilson disease in the Sardinian population—evidence of a founder effect. Hum Mutat 1999; 14: 294–303
   PubMed Web of Science ®Google Scholar
• Mak C M, Lam C W, Tam S, Lai C L, Chan L Y, Fan S T, Lau Y L, Lai S T, Yuen P, Hui J, Fu C C, Wong K S, Mak W L, Tze K, Tong S F, Lau A, Leung N, Hui A, Cheung K M, Ko C H, Chan Y K, Ma O, Chau T N, Chiu A, Chan Y W. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008; 53: 55–63
   Google Scholar
• Schilsky M L, Shneider B. Population screening for Wilson's disease. J Pediatr 2002; 140: 499–501
   Google Scholar
• Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997; 27: 358–362
   PubMed Web of Science ®Google Scholar
• Matsuda I. Screening for Wilson's disease. Lancet 1978; 1: 562
   Google Scholar
• Wilson J MG, Jungner G. Principles and practice of screening for disease. Bol Oficina Sanit Panam 1968; 65: 281–393
   PubMedGoogle Scholar
• Khoury M J, McCabe L L, McCabe E R. Population screening in the age of genomic medicine. N Engl J Med 2003; 348: 50–58
   PubMed Web of Science ®Google Scholar
• Arima M. Wilson's disease–evolutive panorama of diagnosis and treatment in the last forty years. No To Hattatsu 1995; 27: 96–103
   Google Scholar
• Wilson D C, Phillips M J, Cox D W, Roberts E A. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr 2000; 137: 719–722
   PubMed Web of Science ®Google Scholar
• Pooya A AA, Eslami N S, Haghighat M. Wilson disease in southern Iran. Turk J Gastroenterol 2005; 16: 71–74
   PubMedGoogle Scholar
• Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 2005; 41: 668–670
   PubMed Web of Science ®Google Scholar
• Ko S, Lee T, Ng S, Lin J, Cheng Y. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl. Abdom Imaging 1998; 23: 56–59
   PubMedGoogle Scholar
• Beyersdorff A, Findeisen A. Morbus Wilson: case report of a two-year-old child as first manifestation. Scand J Gastroenterol 2006; 41: 496–497
   PubMed Web of Science ®Google Scholar
• Fitzgerald M A, Gross J B, Goldstein N P, Wahner H W, McCall J T. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. Mayo Clin Proc 1975; 50: 438–442
   PubMed Web of Science ®Google Scholar
• Czlonkowska A, Rodo M. Late onset of Wilson's disease. Report of a family. Arch Neurol 1981; 38: 729–730
   Google Scholar
• Ross M E, Jacobson I M, Dienstag J L, Martin J B. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol 1985; 17: 411–413
   Google Scholar
• Danks D M, Metz G, Sewell R, Prewett E J. Wilson's disease in adults with cirrhosis but no neurological abnormalities. BMJ 1990; 301: 331–332
   Google Scholar
• Hefter H, Weiss P, Wesch H, Stremmel W, Feist D, Freund H J. Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand 1995; 91: 302–305
   Google Scholar
• Gow P J, Smallwood R A, Angus P W, Smith A L, Wall A J, Sewell R B. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000; 46: 415–419
   PubMed Web of Science ®Google Scholar
• Pilloni L, Lecca S, Coni P, Demelia L, Pilleri G, Spiga E, Faa G, Ambu R. Wilson's disease with late onset. Dig Liver Dis 2000; 32: 180
   Google Scholar
• Perri R E, Hahn S H, Ferber M J, Kamath P S. Wilson Disease—keeping the bar for diagnosis raised. Hepatology 2005; 42: 974
   Google Scholar
• Dib N, Valsesia E, Malinge M C, Mauras Y, Misrahi M, Cales P. Late onset of Wilson's disease in a family with genetic haemochromatosis. Eur J Gastroenterol Hepatol 2006; 18: 43–47
   PubMed Web of Science ®Google Scholar
• Chappuis P, Callebert J, Quignon V, Woimant F, Laplanche J L. Late neurological presentations of Wilson disease patients in French population and identification of 8 novel mutations in the ATP7B gene. J Trace Elem Med Biol 2007; 21: 37–42
   Google Scholar
• Sohtaoglu M, Ergin H, Ozekmekci S, Gokdemir S, Sonsuz A, Arici C. Patient with late-onset Wilson's disease: deterioration with penicillamine. Mov Disord 2007; 22: 290–291
   Google Scholar
• Xuan A, Bookman I, Cox D W, Heathcote J. Three atypical cases of Wilson disease: assessment of the Leipzig scoring system in making a diagnosis. J Hepatol 2007; 47: 428–433
   Google Scholar
• Ferenci P, Czlonkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt H T, Stremmel W. Late-onset Wilson's disease. Gastroenterology 2007; 132: 1294–1298
   PubMed Web of Science ®Google Scholar
• Roberts E A, Schilsky M L. A practice guideline on Wilson disease. Hepatology 2003; 37: 1475–1492
   PubMed Web of Science ®Google Scholar
• Lin J J, Lin K L, Wang H S, Wong M C. Psychological presentations without hepatic involvement in Wilson disease. Pediatr Neurol 2006; 35: 284–286
   Google Scholar
• Wichowicz H M, Cubala W J, Slawek J. Wilson's disease associated with delusional disorder. Psychiatry Clin Neurosci 2006; 60: 758–760
   PubMed Web of Science ®Google Scholar
• Robertson S, Carney P W. Depression and chorea. Diagnosis: Wilson's disease. J Clin Neurosci 2007; 14: 872, 917–918
   Google Scholar
• Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23: 139–142
   PubMed Web of Science ®Google Scholar
• Czlonkowska A, Tarnacka B, Moller J C, Leinweber B, Bandmann O, Woimant F, Oertel W H. Unified Wilson's Disease Rating Scale-a proposal for the neurological scoring of Wilson's disease patients. Neurol Neurochir Pol 2007; 41: 1–12
   PubMed Web of Science ®Google Scholar
• Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987; 146: 261–265
   PubMed Web of Science ®Google Scholar
• Lehr H, Pauschinger M, Pittke E, Kurrle E, Heimpel H. Haemolytic anaemia as initial manifestation of Wilson's disease. Blut 1988; 56: 45–46
   Google Scholar
• Grudeva-Popova J G, Spasova M I, Chepileva K G, Zaprianov Z H. Acute hemolytic anemia as an initial clinical manifestation of Wilson's disease. Folia Med (Plovdiv) 2000; 42: 42–46
   Google Scholar
• Michel M, Lafaurie M, Noel V, Pico L, Bastie A, Godeau B, Schaeffer A. Hemolytic anemia disclosing Wilson's disease. Report of 2 cases. Rev Med Interne 2001; 22: 280–283
   PubMed Web of Science ®Google Scholar
• Leggio L, Addolorato G, Loudianos G, Abenavoli L, Lepori M B, Vecchio F M, Rapaccini G L, De Virgiliis S, Gasbarrini G. A new mutation of Wilson's disease P-type ATPase gene in a patient with cirrhosis and coombs-positive hemolytic anemia. Dig Dis Sci 2006; 51: 34–38
   Google Scholar
• Aydinli M, Harmanci O, Ersoy O, Iskit A T, Ozcebe O, Abbasoglu O, Bayraktar Y. Two unusual cases with Wilson's disease: hepatoma and fulminant hepatitis treated with plasma exchange. J Natl Med Assoc 2006; 98: 1989–1991
   Google Scholar
• Xu R, Bu-Ghanim M, Fiel M I, Schiano T, Cohen E, Thung S N. Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis 2007; 27: 122–127
   Google Scholar
• Krysiak R, Okopien B. Whipple's triad as a clinical manifestation of hepatolenticular degeneration. Pol Arch Med Wewn 2007; 117: 53–55
   Google Scholar
• Lau J Y, Lai C L, Wu P C, Pan H Y, Lin H J, Todd D. Wilson's disease: 35 year's experience. Q J Med 1990; 75: 597–605
   Google Scholar
• Erkan T, Aktuglu C, Gulcan E M, Kutlu T, Cullu F, Apak H, Tumay G T. Wilson disease manifested primarily as amenorrhea and accompanying thrombocytopenia. J Adolesc Health 2002; 31: 378–380
   Google Scholar
• Schagen van Leeuwen J H, Christiaens G C, Hoogenraad T U. Recurrent abortion and the diagnosis of Wilson disease. Obstet Gynecol 1991; 78: 547–549
   Google Scholar
• Mustafa M S, Shamina A H. Five successful deliveries following 9 consecutive spontaneous abortions in a patient with Wilson disease. Aust N Z J Obstet Gynaecol 1998; 38: 312–314
   PubMedGoogle Scholar
• Rosenoer V M, Michell R C. Skeletal changes in Wilson's disease (hepato-lenticular degeneration). Br J Radiol 1959; 32: 805–809
   Google Scholar
• Mindelzun R, Elkin M, Scheinberg I H, Sternlieb I. Skeletal changes in Wilson's disease. A radiological study. Radiology 1970; 94: 127–132
   Google Scholar
• Pan H Y, Huang C Y, Lai C L. Wilson's disease in a patient presenting with skeletal abnormalities. Orthopedics 1985; 8: 742–744
   Google Scholar
• Balint G, Szebenyi B. Hereditary disorders mimicking and/or causing premature osteoarthritis. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 219–250
   Google Scholar
• Papapetropoulos S, Singer C. Painless legs moving toes in a patient with Wilson's disease. Mov Disord 2006; 21: 579–580
   Google Scholar
• Kumar T S, Moses P D. Isolated tongue involvement—an unusual presentation of Wilson's disease. J Postgrad Med 2005; 51: 337
   Google Scholar
• Polychronopoulos P, Argyriou A A, Papapetropoulos S, Gourzis P, Rigas G, Chroni E. Wilson's disease and benign epilepsy of childhood with centrotemporal (rolandic) spikes. Epilepsy Behav 2006; 8: 438–441
   Google Scholar
• Pendlebury S T, Rothwell P M, Dalton A, Burton E A. Strokelike presentation of Wilson disease with homozygosity for a novel T766R mutation. Neurology 2004; 63: 1982–1983
   Google Scholar
• Kumar S. Wilson's disease presenting as status epilepticus. Indian Pediatr 2005; 42: 492–493
   Google Scholar
• Shukla R, Desai P, Vinod P. Wilson's disease presenting as status epilepticus. J Assoc Physicians India 2006; 54: 887–889
   Google Scholar
• Gronlund J, Nanto-Salonen K, Venetoklis J, Holmberg R L, Heinonen A, Stahlberg M R. Poor cognitive development and abdominal pain: Wilson's disease. Scand J Gastroenterol 2006; 41: 361–364
   PubMed Web of Science ®Google Scholar
• Hoppe B, Neuhaus T, Superti-Furga A, Forster I, Leumann E. Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease. Nephron 1993; 65: 460–462
   Google Scholar
• Laufer J, Passwell J, Lotan D, Boichis H. Screening for Wilson's disease in the investigation of hematuria. Isr J Med Sci 1992; 28: 367–369
   Google Scholar
• Sarles J, Durand J M, Scheiner C, Picon G. Wilson disease, IgA glomerulonephritis and vascular purpura: an incidental association?. Arch Fr Pediatr 1993; 50: 501–504
   Google Scholar
• Gunduz Z, Dusunsel R, Anarat A. Wilson cirrhosis associated with membranoproliferative glomerulonephritis. Nephron 1996; 74: 497–498
   PubMed Web of Science ®Google Scholar
• Kalra V, Khurana D, Mittal R. Wilson's disease–early onset and lessons from a pediatric cohort in India. Indian Pediatr 2000; 37: 595–601
   Google Scholar
• Kalra V, Mahajan S, Kesarwani P K. Rare presentation of Wilson's disease: a case report. Int Urol Nephrol 2004; 36: 289–291
   Google Scholar
• Chu C C, Huang C C, Chu N S. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease. Nephron 1996; 73: 477–479
   Google Scholar
• Chakraborty P P, Mandal S K, Bandyopadhyay D, Bandyopadhyay R, Chowdhury S R. Recurrent limb weakness as initial presentation of Wilson's disease. Indian J Gastroenterol 2007; 26: 36–38
   Google Scholar
• Narayanan P, Chetan G, Mahadevan S. Wilson's disease presenting as respiratory failure. Indian J Pediatr 2006; 73: 99–100
   Google Scholar
• Atanassova P A, Panchovska M S, Tzvetanov P, Chalakova N T, Masaldzhieva R I, Dimitrov B D. Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report. Eur Neurol 2006; 55: 42–43
   Google Scholar
• Azevedo E M, Scaff M, Barbosa E R, Neto A E, Canelas H M. Heart involvement in hepatolenticular degeneration. Acta Neurol Scand 1978; 58: 296–303
   PubMed Web of Science ®Google Scholar
• Kuan P. Cardiac Wilson's disease. Chest 1987; 91: 579–583
   PubMed Web of Science ®Google Scholar
• Firneisz G, Szonyi L, Ferenci P, Gorog D, Nemes B, Szalay F. Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol 2001; 96: 2269–2271
   Google Scholar
• Firneisz G, Szonyi L, Ferenci P, Willheim C, Horvath A, Folhoffer A, Tulassay Z, Szalay F. The other mutation is found: follow-up of an exceptional family with Wilson disease. Am J Gastroenterol 2004; 99: 2504–2505
   Google Scholar
• Bull P C, Thomas G R, Rommens J M, Forbes J R, Cox D W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993; 5: 327–337
   PubMed Web of Science ®Google Scholar
• Petrukhin K, Fischer S G, Pirastu M, Tanzi R E, Chernov I, Devoto M, Brzustowicz L M, Cayanis E, Vitale E, Russo J J, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 1993; 5: 338–343
   PubMed Web of Science ®Google Scholar
• Tanzi R E, Petrukhin K, Chernov I, Pellequer J L, Wasco W, Ross B, Romano D M, Parano E, Pavone L, Brzustowicz L M, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344–350
   PubMed Web of Science ®Google Scholar
• Petrukhin K, Lutsenko S, Chernov I, Ross B M, Kaplan J H, Gilliam T C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994; 3: 1647–1656
   PubMed Web of Science ®Google Scholar
• La Fontaine S, Mercer J F. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys 2007; 463: 149–167
   PubMed Web of Science ®Google Scholar
• Forbes J R, Cox D W. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum Mol Genet 2000; 9: 1927–1935
   PubMed Web of Science ®Google Scholar
• de Bie P, van de Sluis B, Burstein E, van de Berghe P V, Muller P, Berger R, Gitlin J D, Wijmenga C, Klomp L W. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 2007; 133: 1316–1326
   PubMed Web of Science ®Google Scholar
• Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006; 120: 151–159
   PubMed Web of Science ®Google Scholar
• Thomas G R, Forbes J R, Roberts E A, Walshe J M, Cox D W. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995; 9: 210–217
   PubMed Web of Science ®Google Scholar
• Firneisz G, Lakatos P L, Szalay F, Polli C, Glant T T, Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 2002; 108: 23–28
   PubMed Web of Science ®Google Scholar
• Panagiotakaki E, Tzetis M, Manolaki N, Loudianos G, Papatheodorou A, Manesis E, Nousia-Arvanitakis S, Syriopoulou V, Kanavakis E. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A 2004; 131A: 168–173
   Google Scholar
• Cox D W, Prat L, Walshe J M, Heathcote J, Gaffney D. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry. Hum Mutat 2005; 26: 280
   Google Scholar
• Gromadzka G, Schmidt H H, Genschel J, Bochow B, Rodo M, Tarnacka B, Litwin T, Chabik G, Czlonkowska A. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord 2006; 21: 245–248
   PubMed Web of Science ®Google Scholar
• Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G, Osztovits J, Kosa J P, Willheim-Polli C, Szonyi L, Abonyi M, Lakatos P L, Szalay F. Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease. Eur J Gastroenterol Hepatol 2007; 19: 105–111
   PubMedGoogle Scholar
• Thomas G R, Roberts E A, Walshe J M, Cox D W. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995; 56: 1315–1319
   PubMed Web of Science ®Google Scholar
• Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M, Mabuchi H. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 2000; 15: 454–462
   PubMed Web of Science ®Google Scholar
• Wu Z Y, Wang N, Lin M T, Fang L, Murong S X, Yu L. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in chinese patients with Wilson disease. Arch Neurol 2001; 58: 971–976
   Google Scholar
• Yoo H W. Identification of novel mutations and the three most common mutations in the human ATP7B gene of Korean patients with Wilson disease. Genet Med 2002; 4: 43S–48S
   PubMed Web of Science ®Google Scholar
• Liu X Q, Zhang Y F, Liu T T, Hsiao K J, Zhang J M, Gu X F, Bao K R, Yu L H, Wang M X. Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. World J Gastroenterol 2004; 10: 590–593
   PubMed Web of Science ®Google Scholar
• Wan L, Tsai C H, Tsai Y, Hsu C M, Lee C C, Tsai F J. Mutation analysis of Taiwanese Wilson disease patients. Biochem Biophys Res Commun 2006; 345: 734–738
   Google Scholar
• Kenney S M, Cox D W. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007; 28: 1171–1177
   PubMed Web of Science ®Google Scholar
• Swinkels D W, Janssen M C, Bergmans J, Marx J J. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006; 52: 950–968
   PubMed Web of Science ®Google Scholar
• Wang L, Freedman S D. Laboratory tests for the diagnosis of cystic fibrosis. Am J Clin Pathol 2002; 117(Suppl 1)S109–115
   Google Scholar
• Lovicu M, Dessi V, Zappu A, De Virgiliis S, Cao A, Loudianos G. Efficient strategy for molecular diagnosis of Wilson disease in the sardinian population. Clin Chem 2003; 49: 496–498
   Google Scholar
• Weirich G, Cabras A D, Serra S, Coni P P, Nurchi A M, Faa G, Hofler H. Rapid identification of Wilson's disease carriers by denaturing high-performance liquid chromatography. Prev Med 2002; 35: 278–284
   Google Scholar
• Huster D, Weizenegger M, Kress S, Mossner J, Caca K. Rapid detection of mutations in Wilson disease gene ATP7B by DNA strip technology. Clin Chem Lab Med 2004; 42: 507–510
   PubMedGoogle Scholar
• Gupta A, Maulik M, Nasipuri P, Chattopadhyay I, Das S K, Gangopadhyay P K, Ray K. Molecular diagnosis of Wilson disease using prevalent mutations and informative single-nucleotide polymorphism markers. Clin Chem 2007; 53: 1601–1608
   PubMedGoogle Scholar
• Polakova H, Katrincsakova B, Minarik G, Ferakova E, Ficek A, Baldovic M, Kadasi L. Detection of His1069Gln mutation in Wilson disease by bidirectional PCR amplification of specific alleles (BI-PASA) test. Gen Physiol Biophys 2007; 26: 91–96
   Google Scholar
• Gu Y H, Kodama H, Du S L, Gu Q J, Sun H J, Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet 2003; 64: 479–484
   PubMed Web of Science ®Google Scholar
• Park S, Park J Y, Kim G H, Choi J H, Kim K M, Kim J B, Yoo H W. Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease. Hum Mutat 2007; 28: 1108–1113
   Google Scholar
• Shimizu N, Nakazono H, Takeshita Y, Ikeda C, Fujii H, Watanabe A, Yamaguchi Y, Hemmi H, Shimatake H, Aoki T. Molecular analysis and diagnosis in Japanese patients with Wilson's disease. Pediatr Int 1999; 41: 409–413
   PubMedGoogle Scholar
• Lam C W, Mak C M. Allele dropout in PCR-based diagnosis of Wilson disease: mechanisms and solutions. Clin Chem 2006; 52: 517–520
   Google Scholar
• Loudianos G, Dessi V, Lovicu M, Angius A, Kanavakis E, Tzetis M, Kattamis C, Manolaki N, Vassiliki G, Karpathios T, Cao A, Pirastu M. Haplotype and mutation analysis in Greek patients with Wilson disease. Eur J Hum Genet 1998; 6: 487–491
   Google Scholar
• Tsai C H, Tsai F J, Wu J Y, Chang J G, Lee C C, Lin S P, Yang C F, Jong Y J, Lo M C. Mutation analysis of Wilson disease in Taiwan and description of six new mutations. Hum Mutat 1998; 12: 370–376
   Google Scholar
• Loudianos G, Dessi V, Lovicu M, Angius A, Altuntas B, Giacchino R, Marazzi M, Marcellini M, Sartorelli M R, Sturniolo G C, Kocak N, Yuce A, Akar N, Pirastu M, Cao A. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet 1999; 36: 833–836
   PubMed Web of Science ®Google Scholar
• Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol 1991; 238: 281–287
   PubMed Web of Science ®Google Scholar
• Steindl P, Ferenci P, Dienes H P. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997; 113: 212–218
   PubMed Web of Science ®Google Scholar
• Yuce A, Kocak N, Demir H, Gurakan F, Ozen H, Saltik I N, Ozcay F. Evaluation of diagnostic parameters of Wilson's disease in childhood. Indian J Gastroenterol 2003; 22: 4–6
   Google Scholar
• Gheorghe L, Popescu I, Iacob S, Gheorghe C, Vaidan R, Constantinescu A, Iacob R, Becheanu G, Angelescu C, Diculescu M. Wilson's Disease: a challenge of diagnosis. The 5-year experience of a tertiary centre. Rom J Gastroenterol 2004; 13: 179–185
   Google Scholar
• Karim M B, Rahman M M, Islam M S. Wilson's disease with hepatic presentation in childhood. Mymensingh Med J 2007; 16: 29–32
   Google Scholar
• Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007; 56: 115–120
   PubMed Web of Science ®Google Scholar
• Taly A B, Meenakshi-Sundaram S, Sinha S, Swamy H S, Arunodaya G R. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007; 86: 112–121
   PubMed Web of Science ®Google Scholar
• Fleming C R, Dickson E R, Hollenhorst R W, Goldstein N P, McCall J T, Baggenstoss A H. Pigmented corneal rings in a patient with primary biliary cirrhosis. Gastroenterology 1975; 69: 220–225
   PubMed Web of Science ®Google Scholar
• Fleming C R, Dickson E R, Wahner H W, Hollenhorst R W, McCall J T. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977; 86: 285–288
   PubMedGoogle Scholar
• Rimola A, Bruguera M, Rodes J. Kayser-Fleischer-like ring in a cryptogenic cirrhosis. Arch Intern Med 1978; 138: 1857–1858
   Google Scholar
• Frommer D, Morris J, Sherlock S, Abrams J, Newman S. Kayser-Fleischer-like rings in patients without Wilson's disease. Gastroenterology 1977; 72: 1331–1335
   Google Scholar
• Hellman N E, Gitlin J D. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22: 439–458
   PubMed Web of Science ®Google Scholar
• Matsuda I, Pearson T, Holtzman N A. Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr Res 1974; 8: 821–824
   PubMed Web of Science ®Google Scholar
• Gitlin D, Janeway C A. Turnover of the copper and protein moieties of ceruloplasmin. Nature 1960; 185: 693
   Google Scholar
• Sternlieb I, Morell A G, Tucker W D, Greene M W, Scheinberg I H. The incorporation of copper into ceruloplasmin in vivo: studies with copper and copper. J Clin Invest 1961; 40: 1834–1840
   PubMedGoogle Scholar
• Sternlieb I, Van den Hamer C J, Morell A G, Alpert S, Gregoriadis G, Scheinberg I H. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology 1973; 64: 99–105
   PubMed Web of Science ®Google Scholar
• Pojerova A, Tovarek J. Ceruloplasmin in early childhood. Acta Paediatr 1960; 49: 113–120
   Google Scholar
• Schenker I F, Shemesh A, Polishuk W Z. Serum ceruloplasmin levels in normal pregnancy and in newborn infants. Harefuah 1971; 81: 362–363
   Google Scholar
• Shokeir M H. Investigations on the nature of ceruloplasmin deficiency in the newborn. Clin Genet 1971; 2: 223–227
   Google Scholar
• Mora F, Quesada T, Pena J, Osorio C. Immunological and oxidase measurement of ceruloplasmin in pregnant women and newborn (author's transl). Rev Esp Fisiol 1976; 32: 103–106
   PubMedGoogle Scholar
• Fryer A A, Jones P, Strange R, Hume R, Bell J E. Plasma protein levels in normal human fetuses: 13 to 41 weeks' gestation. Br J Obstet Gynaecol 1993; 100: 850–855
   Google Scholar
• Galinier A, Periquet B, Lambert W, Garcia J, Assouline C, Rolland M, Thouvenot J P. Reference range for micronutrients and nutritional marker proteins in cord blood of neonates appropriated for gestational ages. Early Hum Dev 2005; 81: 583–593
   Google Scholar
• Mak C M, Tam S, Fan S T, Liu C L, Lam C W. Wilson's disease: a patient undiagnosed for 18 years. Hong Kong Med J 2006; 12: 154–158
   PubMedGoogle Scholar
• Cox D W. Factors influencing serum ceruloplasmin levels in normal individuals. J Lab Clin Med 1966; 68: 893–904
   PubMedGoogle Scholar
• Kumar S, Thapa B, Kaur G, Prasad R. Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity. Mol Cell Biochem 2007; 294: 1–10
   PubMed Web of Science ®Google Scholar
• Whicher J T, Ritchie R F, Johnson A M, Baudner S, Bienvenu J, Blirup-Jensen S, Carlstrom A, Dati F, Ward A M, Svendsen P J. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994; 40: 934–938
   PubMed Web of Science ®Google Scholar
• Johnson A M, Whicher J T, Ledue T B, Carlstrom A, Itoh Y, Petersen P H. Effect of a new international reference preparation for proteins in human serum (certified reference material 470) on results of the College of American Pathologists Surveys for plasma proteins. Arch Pathol Lab Med 2000; 124: 1496–1501
   Google Scholar
• Beetham R, White P, Riches P, Bullock D, MacKenzie F. Use of CRM 470/RPPHS has not achieved true consensus for ceruloplasmin measurement. Clin Chem 2002; 48: 2293–2294
   Google Scholar
• George S, Matthai S A, Sosamma M M, Sukumaran T U. Menkes' kinky hair syndrome. Indian J Pediatr 2005; 72: 891–892
   Google Scholar
• Subotzky E F, Heese H D, Sive A A, Dempster W S, Sacks R, Malan H. Plasma zinc, copper, selenium, ferritin and whole blood manganese concentrations in children with kwashiorkor in the acute stage and during refeeding. Ann Trop Paediatr 1992; 12: 13–22
   PubMed Web of Science ®Google Scholar
• Stec J, Podracka L, Pavkovcekova O, Kollar J. Zinc and copper metabolism in nephrotic syndrome. Nephron 1990; 56: 186–187
   Google Scholar
• Kamireddy R, Kavuri S, Devi S, Vemula H, Chandana D, Harinarayanan S, James R, Rao A. Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 2002; 325: 147–150
   PubMedGoogle Scholar
• O'Donnell D, Myers A M. Intestinal lymphangiectasia with protein losing enteropathy, toxic copper accumulation and hypoparathyroidism. Aust N Z J Med 1990; 20: 167–169
   Google Scholar
• Tan J C, Burns D L, Jones H R. Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy. JPEN J Parenter Enteral Nutr 2006; 30: 446–450
   Google Scholar
• Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 2003; 23: 345–350
   PubMed Web of Science ®Google Scholar
• Harris Z L. Not all absent serum ceruloplasmin is Wilson disease: a review of aceruloplasminemia. J Investig Med 2002; 50: S236–S238
   Google Scholar
• Sternlier I, Morell A G, Bauer C D, Combes B, De Bobes-Sternberg S, Schein-Berg I H. Detection of the heterozygous carrier of the Wilson's disease gene. J Clin Invest 1961; 40: 707–715
   Google Scholar
• Yang X, Tong D J, Liang J, Zhang Y H, Lei J H, He X E, He G. Ceruloplasmin level of patients with liver disease in China. Zhonghua Nei Ke Za Zhi 2005; 44: 13–15
   Google Scholar
• Schilsky M L, Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology 1997; 113: 350–353
   Google Scholar
• Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson disease. Lancet 1993; 342: 56–57
   Google Scholar
• Walshe J M. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem 2003; 40: 115–121
   PubMed Web of Science ®Google Scholar
• Hohbadel D C, McNeely M D, Sunderman F W. Automated bichromatic analysis of serum ceruloplasmin. Ann Clin Lab Sci 1975; 5: 65–70
   Google Scholar
• Winkles J, Jones A F, Winyard P, Blake D R, Lunec J. An automated method for the kinetic measurement of ferroxidase activity. Ann Clin Biochem 1988; 25: 250–254
   Google Scholar
• Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998; 44: 2313–2319
   PubMed Web of Science ®Google Scholar
• Twomey P J, Viljoen A, House I M, Reynolds T M, Wierzbicki A S. Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice. J Clin Pathol 2006; 59: 867–869
   Google Scholar
• Bohrer D, Do Nascimento P C, Ramirez A G, Mendonca J K, De Carvalho L M, Pomblum S C. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clin Chim Acta 2004; 345: 113–121
   Google Scholar
• Gaffney D, Fell G S, O'Reilly D SJ. ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol 2000; 53: 807–812
   PubMed Web of Science ®Google Scholar
• Twomey P J, Viljoen A, House I M, Reynolds T M, Wierzbicki A S. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice. Clin Chem 2005; 51: 1558–1559
   PubMed Web of Science ®Google Scholar
• Ricos C, Alvarez V, Cava F, Garcia-Lario J V, Hernandez A, Jimenez C V, Minchinela J, Perich C, Simon M. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59: 491–500
   PubMed Web of Science ®Google Scholar
• Ricos C, Cava F, Garcia-Lario J V, Hernandez A, Iglesias N, Jimenez C V, Minchinela J, Perich C, Simon M, Domenech M V, Alvarez V. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004; 64: 175–184
   PubMed Web of Science ®Google Scholar
• Ricos C, Iglesias N, Garcia-Lario J V, Simon M, Cava F, Hernandez A, Perich C, Minchinela J, Alvarez V, Domenech M V, Jimenez C V, Biosca C, Tena R. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007; 44: 343–352
   PubMed Web of Science ®Google Scholar
• Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat A P, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992; 15: 609–615
   PubMed Web of Science ®Google Scholar
• Muller T, Koppikar S, Taylor R M, Carragher F, Schlenck B, Heinz-Erian P, Kronenberg F, Ferenci P, Tanner S, Siebert U, Staudinger R, Mieli-Vergani G, Dhawan A. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol 2007; 47: 270–276
   PubMedGoogle Scholar
• Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, Datz C, Hackl F, Wrba F, Bauer P, Lorenz O. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease. Clin Gastroenterol Hepatol 2005; 3: 811–818
   PubMed Web of Science ®Google Scholar
• McDonald J A, Snitch P, Painter D, Hensley W, Gallagher N D, McCaughan G W. Striking variability of hepatic copper levels in fulminant hepatic failure. J Gastroenterol Hepatol 1992; 7: 396–398
   PubMedGoogle Scholar
• Caprai S, Loudianos G, Massei F, Gori L, Lovicu M, Maggiore G. Direct diagnosis of Wilson disease by molecular genetics. J Pediatr 2006; 148: 138–140
   Google Scholar
• Prashanth L K, Taly A B, Sinha S, Arunodaya G R, Swamy H S. Wilson's disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004; 75: 907–909
   PubMed Web of Science ®Google Scholar
• Walshe J M. Penicillamine: the treatment of first choice for patients with Wilson's disease. Mov Disord 1999; 14: 545–550
   PubMed Web of Science ®Google Scholar
• Brewer G J. Penicillamine should not be used as initial therapy in Wilson's disease. Mov Disord 1999; 14: 551–554
   PubMed Web of Science ®Google Scholar
• LeWitt P A. Penicillamine as a controversial treatment for Wilson's disease. Mov Disord 1999; 14: 555–556
   Google Scholar
• Brewer G J, Dick R D, Johnson V D, Fink J K, Kluin K J, Daniels S. Treatment of Wilson's disease with zinc XVI: Treatment during the pediatric years. J Lab Clin Med 2001; 137: 191–198
   PubMed Web of Science ®Google Scholar
• Klevay L M. Using zinc to remove copper from pediatric patients with Wilson's disease. J Lab Clin Med 2001; 138: 214
   Google Scholar
• Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli M R, Carelli F, Nobili V. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005; 145: 139–143
   PubMed Web of Science ®Google Scholar
• Brewer G J, Askari F K. Wilson's disease: clinical management and therapy. J Hepatol 2005; 42(Suppl 1)S13–S21
   Google Scholar
• Hoogenraad T U. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006; 28: 141–146
   PubMed Web of Science ®Google Scholar
• Macintyre G, Gutfreund K S, Martin W R, Camicioli R, Cox D W. Value of an enzymatic assay for the determination of serum ceruloplasmin. J Lab Clin Med 2004; 144: 294–301
   Google Scholar
• Pinter R, Hogge W A, McPherson E. Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am J Med Genet A 2004; 128: 294–298
   Google Scholar
• Ha-Hao D, Merle U, Hofmann C, Wesch H, Doll J, Auburger G, Tuma S, Strauss M, Stremmel W. Chances and shortcomings of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats. Z Gastroenterol 2002; 40: 209–216
   PubMedGoogle Scholar
• Meng Y, Miyoshi I, Hirabayashi M, Su M, Mototani Y, Okamura T, Terada K, Ueda M, Enomoto K, Sugiyama T, Kasai N. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Biochim Biophys Acta 2004; 1690: 208–219
   PubMed Web of Science ®Google Scholar
• Merle U, Encke J, Tuma S, Volkmann M, Naldini L, Stremmel W. Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. Scand J Gastroenterol 2006; 41: 974–982
   PubMed Web of Science ®Google Scholar
• Merle U, Stremmel W, Encke J. Perspectives for gene therapy of Wilson disease. Curr Gene Ther 2007; 7: 217–220
   Google Scholar